Study on pharmacokinetics of ursodexycholic acid in healthy volunteers by HPLC-MS/MS
Zhang Yi-di
Abstract
Zhang Yi-di
Abstract
Objective To establish a HPLC-MS/MS method for determination of ursodexycholic acid in healthy human plasma and study on its pharmacokinetics in healthy human.Methods Twenty male healthy vounlteers were given a single oral dose of ursodexycholic acid 500 mg.Plasma concentrations were determined by HPLC-MS-MS method.The separation was carried out using the Shimadzu VP-ODS column with the mobile phase consisted of A: acetonitrile-H2O(35∶65);B: acetonitrile.The cetirizine was taken as the internal standard.And the plasma concentrations were detected in FSI negative selected ion monitoring mode.Results The standard curve was linear in range of 40.14~1.20×104 ng·mL-1(γ=0.995).The detection limited in the plasma was 40.14 ng·mL-1.RSD of intra-day and inter-day assays were all less than 20% in low concentrations,all less than 15% in middle or high concentrations,while the relativity recovery were 90.46%,86.51% and 93.41% respectively.The pharmacokinetic parameters were as follows:Cmax was(7.18±2.40) μg·mL-1,tmax was(2.80±0.90)h,AUC0-10 was(22.72±6.08)μg·h·mL-1,AUC0-∞ was(23.80±7.60)μg·h·mL-1.Conclusion HPLC-MS/MS method is selective,sensitive and convenient,proved to be suitable for determining concentration of ursodexycholic acid in plasma as well as pharmacokinetics studies.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To establish a HPLC-MS/MS method for determination of ursodexycholic acid in healthy human plasma and study on its pharmacokinetics in healthy human.Methods Twenty male healthy vounlteers were given a single oral dose of ursodexycholic acid 500 mg.Plasma concentrations were determined by HPLC-MS-MS method.The separation was carried out using the Shimadzu VP-ODS column with the mobile phase consisted of A: acetonitrile-H2O(35∶65);B: acetonitrile.The cetirizine was taken as the internal standard.And the plasma concentrations were detected in FSI negative selected ion monitoring mode.Results The standard curve was linear in range of 40.14~1.20×104 ng·mL-1(γ=0.995).The detection limited in the plasma was 40.14 ng·mL-1.RSD of intra-day and inter-day assays were all less than 20% in low concentrations,all less than 15% in middle or high concentrations,while the relativity recovery were 90.46%,86.51% and 93.41% respectively.The pharmacokinetic parameters were as follows:Cmax was(7.18±2.40) μg·mL-1,tmax was(2.80±0.90)h,AUC0-10 was(22.72±6.08)μg·h·mL-1,AUC0-∞ was(23.80±7.60)μg·h·mL-1.Conclusion HPLC-MS/MS method is selective,sensitive and convenient,proved to be suitable for determining concentration of ursodexycholic acid in plasma as well as pharmacokinetics studies.
Key concepts: Pharmacokinetics, Chromatography, Cmax, High-performance liquid chromatography, Chemistry, Acetonitrile, Plasma concentration, Human plasma